Evaluating PI3 Kinase Isoforms Using Transcreener™ ADP Assays
Open Access
- 1 July 2008
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 13 (6) , 476-485
- https://doi.org/10.1177/1087057108319864
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Signalling through Class I PI3Ks in mammalian cellsBiochemical Society Transactions, 2006
- A Robust Screen for Inhibitors and Enhancers of Phosphoinositide-3 Kinase (PI3K) Activities by Ratiometric Fluorescence SuperquenchingSLAS Discovery, 2006
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketidesProceedings of the National Academy of Sciences, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Overcoming Compound Interference in Fluorescence Polarization-Based Kinase Assays Using Far-Red TracersASSAY and Drug Development Technologies, 2004
- A Versatile High-Throughput Screen for Inhibitors of Lipid Kinase Activity: Development of an Immobilized Phospholipid Plate Assay for Phosphoinositide 3-Kinase γSLAS Discovery, 2002
- Kinetic mechanism and ATP‐binding site reactivity of p38γ MAP kinaseFEBS Letters, 1999
- A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3‐kinaseFEBS Letters, 1994